Acorai is developing a non-invasive heart failure monitoring platform that utilizes a unique combination of seismic, acoustic, visual, and electric sensors to measure intracardiac pressures. Their flagship product, the SAVE Sensor System, leverages state-of-the-art machine learning and proprietary datasets to provide accurate, actionable insights for healthcare professionals managing heart failure. With a focus on personalized treatment, Acorai aims to reduce readmission rates and improve patient stability through continuous monitoring. The company is positioned to disrupt the heart failure management market with its innovative technology and ongoing clinical validation studies, including CAPTURE-HF, which aim to confirm the efficacy of their monitoring system against traditional invasive methods.
Something looks off?